Ensemble Manifold Regularized Multi-Modal Graph Convolutional Network for Cognitive Ability Prediction.


Journal

IEEE transactions on bio-medical engineering
ISSN: 1558-2531
Titre abrégé: IEEE Trans Biomed Eng
Pays: United States
ID NLM: 0012737

Informations de publication

Date de publication:
12 2021
Historique:
pubmed: 12 5 2021
medline: 15 12 2021
entrez: 11 5 2021
Statut: ppublish

Résumé

Multi-modal functional magnetic resonance imaging (fMRI) can be used to make predictions about individual behavioral and cognitive traits based on brain connectivity networks. To take advantage of complementary information from multi-modal fMRI, we propose an interpretable multi-modal graph convolutional network (MGCN) model, incorporating both fMRI time series and functional connectivity (FC) between each pair of brain regions. Specifically, our model learns a graph embedding from individual brain networks derived from multi-modal data. A manifold-based regularization term is enforced to consider the relationships of subjects both within and between modalities. Furthermore, we propose the gradient-weighted regression activation mapping (Grad-RAM) and the edge mask learning to interpret the model, which is then used to identify significant cognition-related biomarkers. We validate our MGCN model on the Philadelphia Neurodevelopmental Cohort to predict individual wide range achievement test (WRAT) score. Our model obtains superior predictive performance over GCN with a single modality and other competing approaches. The identified biomarkers are cross-validated from different approaches. This paper develops a new interpretable graph deep learning framework for cognition prediction, with the potential to overcome the limitations of several current data-fusion models. The results demonstrate the power of MGCN in analyzing multi-modal fMRI and discovering significant biomarkers for human brain studies.

Identifiants

pubmed: 33974537
doi: 10.1109/TBME.2021.3077875
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

3564-3573

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM109068
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH104680
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH107354
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103472
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB020407
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB006841
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007595
Pays : United States

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH